Sunshine Biopharma Inc.

Sunshine Biopharma Inc. (SBFM) has registered zero cyber incidents and zero red-flag 8-K filings over the past 90 days, suggesting stable near-term operational continuity. However, low signal in our recent window does not mean low risk—biotech companies face persistent structural vulnerabilities around financing, dilution, and clinical execution that a 90-day snapshot cannot capture. The full $49 Report extends analysis to 12 months of SEC filings, applies our dilution risk scoring model, traces financing history and equity raises, and surfaces AI-detected early warning signals missed by standard screening. The full $49 Report adds comprehensive dilution trajectory, 12-month 8-K context, capital structure trends, and AI risk signals to complete your due diligence.